Andrea Miyahira hosts Marina Sharifi about a multiomic profiling study of metastatic castration-resistant prostate cancer using circulating tumor cells, ctDNA, and RNA sequencing.

Alan Bryce hosts Mary-Ellen Taplin to discuss key recommendations from the 2024 US Prostate Cancer Consensus Conference addressing biochemical recurrence management. Dr. Taplin emphasizes that PSMA ...

Evan Yu is joined by Atish Choudhury to discuss a first-in-human trial combining EZH2 and PARP inhibition in metastatic castration-resistant prostate cancer. Dr. Choudhury explains that EZH2 is an ...

ENZAMET study, IGF-1 cytokines and sphingolipids as prognostic factors in mHSPC, precision metabolic therapy trials, Exploring IGF-1 Pathway Biomarkers and Outcomes in Metastatic Hormone-Sensitive ...

In [18F]F-PSMA-1007 PET imaging, focal bone uptake without morphological correlate (MC) on CT, is often classified as benign. In [68Ga]Ga-PSMA-11, intense focal uptake without MC in a classical ...

Tian Zhang speaks with David Wise about a phase I study combining ONC-392 with lutetium-177 vipivotide tetraxetan in metastatic castration-resistant prostate cancer.

Leslie Ballas speaks with Timothy Showalter about a multimodal artificial intelligence-based prostate cancer test. Dr. Showalter explains how ArteraAI analyzes H&E-stained biopsy slides using computer ...

Enfortumab vedotin (EV) in combination with pembrolizumab (P) has led to a new paradigm for the treatment of metastatic urothelial carcinoma (mUC). Since the presentation of the results of the EV-302 ...

Biochemical recurrence (BCR) after radical prostatectomy exhibits heterogeneous prognostic implications. Recent advancements in imaging and biomarkers have high potential for personalizing care.

properties of Lead-212 and Actinium-225 alpha emitters for prostate cancer therapy, comparing half-lives dosing imaging capabilities and clinical trial progress with early results showing minimal ...

FAP and Nectin-4 targeted radioligand therapies in bladder cancer, highest FAP uptake across tumors, superior lesion detection and treatment, FAP and Nectin-4 Targeted Imaging and Therapy in ...

In this discussion Zachary Klaassen is joined by Jay Raman and Yair Lotan to explore the latest updates in the evaluation of microhematuria. They discuss the unmet need in risk stratifying patients, ...